HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: Systematic analysis applying tissue microarray technique

Urology

Volumn 65, Issue 1, 2005, Pages 176-180

  Langner, Cord ^a   Gross, Christof ^b   Rehak, Peter ^a   Ratschek, Manfred ^a   Rüschoff, Josef ^a   Zigeuner, Richard ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 17; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METASTASIS; POLYSOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; LIFE TABLES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS;

EID: 12844251812     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.08.025     Document Type: Article

References (30)

1. M.A. Olayioye, R.M. Neve, H.A. Lane The ErbB signaling network receptor heterodimerization in development and cancer EMBO J 19 2000 3159 3167
2. S. Ménard, S.M. Pupa, M. Campiglio Biologic and therapeutic role of HER2 in cancer Oncogene 22 2003 6570 6578
3. Z. Latif, A.D. Watters, I. Dunn HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder a role for anti-HER2 therapy? Eur J Cancer 40 2004 56 63
4. M.F. Press, G. Hung, W. Godolphin Sensitivity of HER-2/neu antibodies in archival tissue samples potential source of error in immunohistochemical studies of oncogene expression Cancer Res 54 1994 2771 2777
5. J. Bartlett, E. Mallon, T. Cooke The clinical evaluation of HER-2 status which test to use? J Pathol 199 2003 411 417
6. B. Bjerkehagen, S.D. Fossa, N. Raabe Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe5, chromogranin, laminin and collagen type IV Eur Urol 26 1994 334 339
7. T. Imai, M. Kimura, M. Takeda Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell carcinoma of the upper urinary tract for tumour recurrence at the urinary bladder Br J Cancer 71 1995 69 72
8. J. Kononen, L. Bubendorf, A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
9. L.H. Sobin C. Wittekind TNM Classification of Malignant Tumors 6th ed. 2002 Wiley-Liss New York
10. A. Lopez-Beltran, G. Sauter, T. Gasser Tumours of the urinary system infiltrating urothelial carcinoma J.N. Eble G. Sauter J.I. Epstein World Health Organization Classification of Tumours--Pathology and Genetics--Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon 93 109
11. R. Simon, R. Atefy, U. Wagner HER-2 and TOP2A coamplification in urinary bladder cancer Int J Cancer 207 2003 764 772
12. A. Nocito, L. Bubendorf, M.E. Tinner Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade J Pathol 194 2001 349 357
13. D. Gancberg, A. di Leo, G. Rouas Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma J Clin Pathol 55 2002 315 317
14. S. Krüger, G. Weitsch, H. Büttner Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma relationship with gene amplification, clinicopathological parameters and prognostic outcome Int J Oncol 21 2002 981 987
15. G. Gorgoulis, C. Barbatis, I. Poulias Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder a study in Greek patients Mod Pathol 8 1995 758 764
16. H. Moch, G. Sauter, M.J. Mihatsch p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer Hum Pathol 25 1994 1346 1351
17. M. Underwood, J. Bartlett, J. Reeves C-erB-2 gene amplification a molecular marker in recurrent bladder tumors? Cancer Res 55 1995 2422 2430
18. J.K. Mellon, J. Lunec, C. Wright C-erbB-2 in bladder cancer molecular biology, correlation with epidermal growth factor receptors and prognostic value J Urol 155 1996 321 326
19. N.H. Chow, S.H. Chan, T.S. Tzai Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 1957 1962
20. R.E. Jiminez, M. Hussain, F.J. Bianco Jr HER-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic significance and comparative analysis in primary and metastatic tumors Clin Cancer Res 7 2001 2440 2447
21. R. Gandour-Edwards, P.N. Lara Jr, A.K. Folkins Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer 95 2002 1009 1015
22. G. Sauter, H. Moch, D. Moore Heterogeneity of erbB-2 gene amplification in bladder cancer Cancer Res 53 1993 2199 2203
23. P. Schraml, J. Kononen, L. Bubendorf Tissue microarrays for gene amplification surveys in many different tumor types Clin Cancer Res 5 1999 1966 1975
24. J. Ohta, Y. Miyoshi, H. Uemura Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer Clin Cancer Res 7 2001 2463 2467
25. C.L. Coogan, C.R. Estrada, S. Kapur HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder Urology 63 2004 786 790
26. H. Miyamoto, Y. Kubota, S. Noguchi c-erbB-2 Gene amplification as prognostic markers in human bladder cancer Urology 55 2000 679 683
27. U. Lonn, S. Lonn, S. Friberg Prognostic value of amplification of c-erb-B2 in bladder carcinoma Clin Cancer Res 1 1995 1189 1194
28. A. Lebeau, D. Deimling, C. Kaltz Her-2/neu analysis in archival tissue samples of human breast cancer comparison of immunohistochemistry and fluorescence in situ hybridization J Clin Oncol 19 2001 354 363
29. M. Dowsett, J. Bartlett, I.O. Ellis Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres J Pathol 199 2003 418 423
30. J. Baselga, D. Tripathy, J. Mendelsohn Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER-2/neu-overexpressing metastatic breast cancer J Clin Oncol 14 1996 737 744